X irradiation induces the proapoptotic state independent of the loss of clonogenic ability in Chinese hamster V79 cells

Radiation Research

Volumn 164, Issue 1, 2005, Pages 36-44

  Iizuka, Daisuke ^a   Inanami, Osamu ^a   Matsuda, Akira ^b   Kashiwakura, Ikuo ^c   Asanuma, Taketoshi ^a   Kuwabara, Mikinori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 C ETHYNYL BETA DEXTRO RIBO PENTOFURANOSYL)CYTOSINE; 3' ETHYNYLCYTIDINE; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN WEE1; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL NUCLEUS MEMBRANE; CELL SURVIVAL; CLONOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG DEGRADATION; DRUG EFFECT; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION RESPONSE; WESTERN BLOTTING; X IRRADIATION;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE; CRICETINAE; CRICETULUS; CYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIBROBLASTS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; X-RAYS;

CRICETULUS GRISEUS;

EID: 21244461534     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3393     Document Type: Article

References (24)

1. D. J. Allan, Radiation-induced apoptosis: Its role in a MADCaT (mitosis-apoptosis-differentiation-calcium toxicity) scheme of cytotoxicity mechanisms. Int. J. Radiat. Biol. 62, 145-152 (1992).
2. 2. J. Radiat. Res. 38, 95-102 (1997).
3. K. Satyamoorthy, T. Bogenrieder and H. Meenhard, No longer a molecular black box-new clues to apoptosis and drug resistance in melanoma. Trends Mol. Med. 7, 191-194 (2001).
4. C. J. McGinn, T. S. Lawrence and M. M. Zalupski, On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer. Cancer 95, 933-940 (2002).
5. O. Inanami, D. Iizuka, A. Iwahara, Y. Kon, T. Asanuma, A. Matsuda, K. Kitazato and M. Kuwabara, A novel anticancer ribonucleoside, 1-(3-C-ethynyl-β-ribo-pentofuranosyl) cytosine, enhances radiation-induced cell death in tumor cells. Radiat. Res. 162, 635-645 (2004).
6. H. Hattori, M. Tanaka, M. Fukushima, T. Sasaki and A. Matsuda, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine, 1-(3-C-ethynyl-β-D- ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity. J. Med. Chem. 39, 5005-5011 (1996).
7. S. Takatori, H. Kanda, K. Takenaka, Y. Wataya, A. Matsuda, M. Fukushima, Y. Shimamoto, M. Tanaka and T. Sasaki, Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-β-D-ribo- pentofuranosyl) cytosine and 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)uracil. Cancer Chemother. Pharmacol. 44, 97-104 (1999).
8. G. S. Stein, J. L. Stein, J. B. Lian, T. J. Last, T. Owen and L. McCabe, Synchronization of normal diploid and transformed mammalian cells. In Cell Biology, a Laboratory Handbook, Vol. 1 (J. E. Celis, Ed.), pp. 282-287. Academic Press, San Diego, 1994.
9. R. G. Bristow, S. Benchimol and R. P. Hill, The p53 gene as a modifier of intrinsic radiosensitivity: Implications for radiotherapy. Radiother. Oncol. 40, 197-223 (1996).
10. S. A. Amundson, T. G. Myers and A. J. Fornace, Jr., Roles for p53 in growth arrest and apoptosis: Putting on the brakes after genotoxic stress. Oncogene 17, 3287-3299 (1998).
11. T. Weinert, DNA damage and checkpoint pathways: Molecular anatomy and interactions with repair. Cell 94, 555-558 (1998).
12. C. Cadwell and G. P. Zambetti, The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth. Gene 277, 15-30 (2001).
13. W. Krek and J. A. DeCaprio, Cell synchronization. Methods Enzymol. 254, 114-124 (1995).
14. K. K. Khanna, M. F. Lavin, S. P. Jackson and T. D. Mulhern, ATM, a central controller of cellular responses to DNA damage. Cell Death Differ. 8, 1052-1065 (2001).
15. L. C. Playle, D. J. Hicks, D. Qualtrough and C. Paraskeva, Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines. Br. J. Cancer 87, 352-358 (2002).
16. A. M. Senderowicz and E. A. Sausville, Preclinical and clinical development of cyclin-dependent kinase modulators. J. Natl. Cancer Inst. 92, 376-387 (2000).
17. H. H. Xiao, Y. Makeyev, J. Butler, B. Vikram and W. A. Franklin, 7-Hydroxystaurosporine (UCN-01) preferentially sensitizes cells with a disrupted TP53 to gamma radiation in lung cancer cell lines. Radiat. Res. 158, 84-93 (2002).
18. 2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53. Int. J. Cancer 96, 110-117 (2001).
19. A. Blasina, B. D. Price, G. A. Turenne and C. H. McGowan, Caffeine inhibits the checkpoint kinase ATM. Curr. Biol. 9, 1135-1138 (1999).
20. J. N. Sarkaria, E. C. Busby, R. S. Tibbetts, P. Roos, Y. Taya, L. M. Karnitz and R. T. Abraham, Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59, 4375-4382 (1999).
21. A. Matsuda, M. Fukushima, Y. Wataya and T. Sasaki, A new antitumor nucleoside, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (ECyd), is a potent inhibitor of RNA synthesis. Nucleosid. Nucleotid. 18, 811-814 (1999).
22. A. Azuma, A. Matsuda, T. Sasaki and M. Fukushima, 1-(3-C-Ethynyl-β- D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) 1: antitumor effect and mechanism of action. Nucleosid. Nucleotid. Nucleic Acid 20, 609-619 (2001).
23. M. Osaki, S. Tatebe, A. Goto, H. Hayashi, M. Oshima and H. Ito, 5-Fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: Role of the p53 gene. Apoptosis 2, 221-226 (1997).
24. W. Chaung, L. J. Mi and R. J. Boorstein, The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair. Nucleic Acids Res. 25, 992-994 (1997).